High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effectsBenjamin P. Kleinstiver, J. Keith Joung, Vikram Pattanayak et al.|Nature|2016Cited by 2.7k
Engineered CRISPR-Cas9 nucleases with altered PAM specificitiesBenjamin P. Kleinstiver, J. Keith Joung, Michelle S. Prew et al.|Nature|2015Cited by 1.7k
Enhanced proofreading governs CRISPR–Cas9 targeting accuracyJanice S. Chen, Jennifer A. Doudna, Yavuz S. Dagdas et al.|Nature|2017Cited by 1.2k
Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editingBenjamin P. Kleinstiver, J. Keith Joung, Luca Pinello et al.|Nature Biotechnology|2019Cited by 724
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cellsBenjamin P. Kleinstiver, J. Keith Joung, Shengdar Q. Tsai et al.|Nature Biotechnology|2016Cited by 714